BSEBoard Meeting2h ago · 4 Aug 2026, 03:10 pm
Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Un-audited Standalone ....
Camlin Fine Sciences Ltd · 532834
✦ AI SummaryResults
Camlin Fine Sciences Ltd has scheduled a Board Meeting on August 11, 2026, to consider and approve the Un-audited Standalone and Consolidate Financial Results for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Camlin Fine Sciences Ltd - 532834 - Board Meeting Intimation for Consideration And Approval Of The Un-Audited Standalone And Consolidate Financial Results Of The Company For The Quarter Ended June 30, 2026.
Attachments (1)
📄pdf
Download →
8327027a-7de7-4a15-ae55-8fd51eaf5486.pdf
View document text
August 4, 2026
To, To,
BSE Limited, The Manager,
25, P. J. Towers, Listing Department,
Dalal Street, National Stock Exchange of India Ltd.,
Mumbai – 400 001 Exchange Plaza, Bandra Kurla Complex,
Ref: Company Scrip Code: 532834 Bandra (East), Mumbai- 400051
Ref: Symbol: CAMLINFINE || Series: EQ
Sub: Intimation about the Board Meeting of Camlin Fine Sciences Limited (the “Company”) to be
held on August 11, 2026.
Dear Sir/Madam,
Pursuant to Regulation 29 and other applicable provisions of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the
meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 11,
2026, inter alia to consider and approve the Un-audited Standalone and Consolidate Financial Results
of the Company for the quarter ended June 30, 2026.
Further, the Company has vide its letter dated June 24, 2026 intimated regarding the closure of the
Trading Window for trading in the Company’s equity shares from July 1, 2026, till the expiry of 48 hours
from the date the said financial results are made public.
We request you to take the above on record and disseminate the same on your website.
Thanking you,
Yours faithfully,
For Camlin Fine Sciences Limited
Rahul Sawale
Company Secretary
& V. P. Legal